~~<i id='5F4A4B5D26'><strike id='5F4A4B5D26'><tt id='5F4A4B5D26'><pre id='5F4A4B5D26'></pre></tt></strike></i>~~

Home» comprehensive» knowledge

knowledge

author：fashion 2025-09-29 12:18:33 Page View：576

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Telehealth for opioid use disorder is lifesaving
Next article： In age of alternative facts, a scholarly course on calling out crap

comprehensive

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

FDA approves updated Covid vaccines

ASafewaypharmacistadministersaPfizerCovid-19boosteratavaccinationclinicinOctober2021inSanRafael,Cali

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

10 million people disenrolled from Medicaid over past six months

AdobeMorethan10millionpeopleweredisenrolledfromMedicaidoverthepastsixmonths,accordingtothelatestdata